Comparative Analysis of Thermal Ablation and Hepatectomy for Solitary Colorectal Liver Metastases up to 5 cm: Insights from a Multicenter Trial Emulation on Safety, Effectiveness, and Economic Viability - Report - MDSpire
Advertisement
Comparative Analysis of Thermal Ablation and Hepatectomy for Solitary Colorectal Liver Metastases up to 5 cm: Insights from a Multicenter Trial Emulation on Safety, Effectiveness, and Economic Viability
Clinical Report: Comparative Analysis of Thermal Ablation and Hepatectomy
Overview
This multicenter study evaluates the safety, effectiveness, and economic viability of thermal ablation (TA) versus hepatectomy (HT) for solitary colorectal liver metastases (SCLM) up to 5 cm. The findings suggest that TA may offer a viable alternative to HT, particularly for patients ineligible for surgical resection.
Background
Colorectal cancer is a leading cause of cancer-related mortality, with solitary colorectal liver metastases (SCLM) presenting a significant treatment challenge. While hepatectomy is the standard curative approach, many patients are ineligible due to various factors, necessitating alternative treatments like thermal ablation. Recent guidelines emphasize the importance of multidisciplinary evaluations and the potential role of TA in managing SCLM.
Data Highlights
No numerical data available in the provided source material.
Key Findings
Approximately 38% to 55% of patients with colorectal liver metastases present with a solitary lesion.
Only about 20% of patients meet conventional surgical criteria for hepatectomy due to various limitations.
Thermal ablation techniques, such as radiofrequency and microwave ablation, are less invasive and effective for non-surgical candidates.
Recent trials indicate that thermal ablation is non-inferior to hepatectomy for small colorectal liver metastases (< 3 cm).
This study included 1334 patients after applying strict eligibility criteria for SCLM treatment.
Clinical Implications
The findings support the consideration of thermal ablation as a treatment option for patients with solitary colorectal liver metastases who are not candidates for surgical resection. Clinicians should evaluate the potential benefits of TA in conjunction with multidisciplinary teams to optimize patient outcomes.
Conclusion
Thermal ablation presents a promising alternative to hepatectomy for managing solitary colorectal liver metastases up to 5 cm, particularly in patients with significant comorbidities or those deemed ineligible for surgery. Further studies are warranted to solidify these findings.
